U.S. Life Sciences Stock News

If you are wondering whether Celsius Holdings at around US$44.39 is still reasonably priced or already running ahead of itself, you are not alone. The stock has pulled back recently, with a 7.5% decline over the last week and a 15.6% decline over the last 30 days, even though the 1 year return stands at 95.9%. Recent coverage has focused on Celsius Holdings as a high growth consumer brand in the energy drinks space, with attention on its distribution partnerships and expanding shelf presence...

Plains All American Pipeline (NasdaqGS:PAA) is drawing fresh attention as a high-yield dividend stock after a shift in interest rate expectations. Robust US employment data has led the Federal Reserve to signal that interest rate cuts could be delayed. This changing rate outlook is putting more focus on income ideas, with PAA's dividend profile now featuring more prominently in investor discussions. Plains All American Pipeline operates in the midstream energy space, with assets focused on...

Enterprise Products Partners (EPD) is back on investors’ radar after reporting fourth quarter results featuring record natural gas inlet and NGL fractionation volumes, higher operating margins, and another increase in its quarterly distribution. See our latest analysis for Enterprise Products Partners. The recent earnings beat, completion of a US$1.44b buyback program, and another distribution increase have come alongside a 9.5% 1 month share price return and a 136.3% 5 year total shareholder...

Why GE HealthCare Technologies (GEHC) is on investors’ radar GE HealthCare Technologies (GEHC) has drawn attention after recent share price moves, including a one-month return of about a 7% decline and a past 3 months gain of roughly 8%, raising questions about how its fundamentals line up. See our latest analysis for GE HealthCare Technologies. At a share price of US$78.65, GE HealthCare Technologies has seen a 7.22% 1 month share price decline after a 7.52% 3 month share price return. The 1...

Investors are facing fresh scrutiny of Cytokinetics (NasdaqGS:CYTK) as a formal investigation looks at potential fiduciary duty breaches by certain directors and officers. The inquiry focuses on an alleged omission of a required Risk Evaluation and Mitigation Strategy from the New Drug Application for aficamten. This omission reportedly led to a three month delay in FDA approval, raising questions about governance, disclosure practices and regulatory oversight at the company. Cytokinetics,...

AllianceBernstein Holding (AB) is back in focus after updating investors on January assets under management, which reached US$875b following a 1% month over month move, along with recent earnings showing lower quarterly and full year net income. See our latest analysis for AllianceBernstein Holding. The recent January assets under management update and the latest earnings arrive after a choppy few weeks for the units, with a 7 day share price return of a 4.34% decline, contrasting with a 6.8%...

Cushman & Wakefield (NYSE:CWK) has recently added several senior leaders across key U.S. markets and service lines. New appointments include Gabrielle Harvey and Brendan Callahan in Boston, Kevin Donner in Los Angeles, Damla Gerhart for the Midwest Region, and Gregg Metcalf as Executive Director. These moves expand the firm’s capabilities in tenant representation, portfolio services, capital markets, and regional operations. For investors watching NYSE:CWK, these leadership changes arrive...

If you are wondering whether Cigna Group's current share price lines up with its underlying worth, you are in the right place for a clear valuation walkthrough. Cigna Group recently closed at US$287.61, with returns of 1.1% over the past 7 days, 5.8% over 30 days, 3.0% year to date, and a 2.1% decline over the last year, plus returns of 1.5% over 3 years and 52.9% over 5 years. This mix of short term gains and a softer 1 year return has refocused attention on what investors are paying for...

Green Plains has begun Carbon Capture and Sequestration operations, targeting the low carbon fuel market. The company is starting to benefit from related tax credits tied to these CCS activities. Management is also working on asset sales and debt restructuring to reshape the balance sheet. For investors watching NasdaqGS:GPRE, these moves come with the stock at $13.92 and a mixed performance record. The shares are up 10.0% over the past week, 24.2% over the past month, and 35.4% year to...

Opera (OPRA) raised its revenue outlook for the fourth quarter and full year 2025, while also highlighting strong user and transaction growth in its MiniPay stablecoin wallet across emerging markets. See our latest analysis for Opera. Even with the MiniPay momentum and higher 2025 revenue outlook, Opera’s recent share price performance has been weak, with a 30 day share price return of an 8.62% decline and a 1 year total shareholder return of a 41.06% loss, contrasting with a 3 year total...

United Therapeutics recently completed its Phase 3 TETON-1 trial of inhaled treprostinil in idiopathic pulmonary fibrosis, a double-blind, placebo-controlled 52-week study assessing whether the drug can slow lung function decline. This milestone, building on earlier TETON-2 findings, could be pivotal for expanding the Tyvaso franchise into IPF and informing potential regulatory filings. Next, we’ll examine how completing the TETON-1 Phase 3 IPF trial could reshape United Therapeutics’...

Anterix (ATEX) has just put out its Q3 2026 scorecard, with the latest reported quarter in the data set showing revenue of US$1.6 million and basic EPS of US$2.86, alongside trailing 12 month EPS of US$5.13 on net income of US$95.6 million that includes a one off gain of US$141.8 million. Over the past few reported periods, revenue has stayed in a tight band between roughly US$1.4 million and US$1.6 million per quarter, while basic EPS has moved from losses in early 2025 to positive readings...

Clearway Energy recently reached a new three-year high, reflecting strong technical momentum and renewed investor interest in its clean energy business and income profile. This renewed focus on Clearway’s sizeable dividend is particularly important for investors seeking a combination of long-term infrastructure exposure and regular cash distributions. Next, we’ll explore how this recent momentum, anchored by Clearway’s dividend appeal, interacts with the existing investment narrative and...

In early February 2026, AMETEK, Inc. reported record fourth-quarter and full-year 2025 results, issued earnings and sales guidance for 2026, and earlier this month it approved a 10% increase in its quarterly cash dividend to US$0.34 per share, payable on March 31, 2026 to shareholders of record on March 16, 2026. The combination of higher earnings, strong cash generation, upbeat guidance and a higher indicated annual dividend of US$1.36 per share underlines management’s confidence in the...

Why the DAMAC agreement matters for Cognizant Technology Solutions (CTSH) Cognizant Technology Solutions (CTSH) has drawn fresh attention after signing a three year agreement with DAMAC Group, taking on broad responsibility for DAMAC's IT infrastructure, applications, and AI focused digital transformation efforts. See our latest analysis for Cognizant Technology Solutions. The DAMAC news comes after a sharp pullback, with a 1 day share price return showing a 7.16% decline and a 30 day share...

Danaos Corporation recently reported its fourth-quarter and full-year 2025 results, with Q4 revenue rising to US$266.27 million and net income to US$117.91 million, alongside a declared Q4 2025 dividend of US$0.90 per share payable on March 4, 2026. The company also expanded its contracted revenue backlog to US$4.30 billion, reinforced liquidity with a €500 million seven-year unsecured bond, and moved into LNG-related shipping through a stake in the Alaska LNG project, signaling a broader...

Sezzle (NasdaqCM:SEZL) is partnering with David's Bridal and the Times Square Alliance for a Valentine's Day celebration in Times Square. The initiative features flexible payment options for milestone wedding related purchases, along with on site romantic events such as surprise proposals and vow renewals. The collaboration aims to increase brand visibility for Sezzle by connecting its buy now, pay later offering with high profile, emotionally driven spending moments. For investors watching...

AvalonBay Communities (AVB) has just wrapped up a busy stretch, reporting fourth quarter and full year 2025 results, issuing 2026 earnings guidance, lifting its quarterly dividend, and completing a sizeable share repurchase. See our latest analysis for AvalonBay Communities. At a share price of US$175.26, AvalonBay Communities has seen mixed short term momentum, with a 3.3% 7 day share price return but a 2.9% year to date decline. The 1 year total shareholder return of 17.5% decline contrasts...

If you are wondering whether Dollar General is still good value after a strong run, this article will walk through what the current share price might be implying about the company. The stock closed at US$148.56 recently, with returns of 2.5% over the past week, an 8.6% gain year to date, a 108.4% return over 1 year, but declines of 31.0% over 3 years and 20.8% over 5 years. Recent news coverage has focused on how Dollar General is positioned within US discount retail and how investors are...

Equinix (EQIX) has just put a lot on the table for investors. The company reported detailed Q4 and full year 2025 results, raised its quarterly dividend, and issued fresh 2026 revenue guidance. See our latest analysis for Equinix. The strong earnings rebound, higher dividend and confident 2026 guidance have been met with a sharp re-rating, with a 1 month share price return of 19.54% and a 5 year total shareholder return of 53.84%. This suggests momentum has recently accelerated from a higher...

If you are wondering whether Hilton Grand Vacations is attractively priced right now, the key question is how its current share price lines up with its underlying fundamentals. The stock closed at US$45.32 most recently, with returns of a 2.0% decline over 7 days, a 5.7% decline over 30 days, a 0.4% decline year to date, a 7.1% gain over 1 year, a 5.1% decline over 3 years and a 22.3% gain over 5 years. This gives you a mixed picture of shorter term pressure and longer term...

Century Communities (CCS) is back on investors’ radar after a 10% quarterly dividend increase to $0.32 per share and news of its first luxury townhome community in St. Johns County, Florida. See our latest analysis for Century Communities. Those moves come as Century Communities’ share price sits at US$72.30, with a 90 day share price return of 23.38% and a 1 year total shareholder return of 2.63%, suggesting recent momentum has picked up after a more modest longer term outcome. If this kind...

With no single headline event driving attention to Crane NXT (CXT) today, investors are focusing on its recent share performance and business profile, particularly its role in industrial technology for secure payments and authentication. See our latest analysis for Crane NXT. Crane NXT’s 1 day share price return of 3.42% at a closing price of $53.50 sits within a broader pattern where its 30 day share price return of 7.41% contrasts with a 90 day share price decline of 8.69% and a 1 year...

Ingles Markets, Incorporated reported past first‑quarter 2025 results to December 27, 2025, with sales rising to US$1,372.98 million and net income to US$28.13 million, lifting diluted earnings per share from continuing operations to US$1.48. The sharp improvement in profitability alongside higher sales highlights how Ingles Markets converted top-line growth into stronger earnings efficiency over the quarter. With that backdrop of stronger earnings per share, we’ll now explore what this...